Galectin Therapeutics GALT
$ 2.74
-2.66%
Quarterly report 2024-Q3
added 11-14-2024
Galectin Therapeutics EV/EBITDA Ratio 2011-2024 | GALT
Annual EV/EBITDA Ratio Galectin Therapeutics
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|
-1.92 | -3.61 | -6.75 | -13.7 | -10.2 | -0.645 | -0.407 | -2.67 | -17.1 | -3.11 | -4.99 |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
-0.407 | -17.1 | -5.92 |